申请人:KYOWA HAKKO KOGYO CO., LTD.
公开号:EP0786252A1
公开(公告)日:1997-07-30
An anti-tumor agents against drug-resistant tumors, containing, as the active ingredient, a compound represented by the following formula, or its pharmaceutically-acceptable salt:
wherein X is Cl or Br;
R is NR1R2 (in which R1 and R2 independently represent hydrogen, or a linear or branched alkyl group with 1 to 4 carbon atoms), or
in which R3 is -CH2- or N-CH3.
The anti-tumor agent of the present invention exhibits an excellent anti-tumor activity against tumors resistant to clinical anticancer drugs, and is useful as an anti-tumor agent for drug-resistant tumors.
一种针对抗药性肿瘤的抗肿瘤制剂,其活性成分含有下式所代表的化合物或其药学上可接受的盐:
其中 X 是 Cl 或 Br;
R 是 NR1R2(其中 R1 和 R2 分别代表氢或 1 至 4 个碳原子的直链或支链烷基),或
其中 R3 是-CH2-或 N-CH3。
本发明的抗肿瘤剂对临床抗癌药物耐药的肿瘤具有很好的抗肿瘤活性,可用作耐药肿瘤的抗肿瘤剂。